Sign in
PHAR Stock Price, Chart, Stats & News
Pharming Group N.V.
Save
Pharming Group N.V. (PHAR) does not currently pay a dividend.
740.34M
Market cap
65.38x
Current P/E
212.77x
Forward P/E
PHAR chart
Fundamentals
Gross margin | 88.25% |
Operating margin | 5.92% |
Pretax margin | 3.37% |
Net margin | 0.56% |
Effective tax rate | 85.83% |
ROA | 0.48% |
ROE | 0.89% |
D/E | 0.49x |
Interest coverage ratio | 0.02x |
PHAR valuation
P/E | 65.38x |
P/S | 3.00x |
P/B | 4.58x |
P/CF | 22.39x |
P/FCF | 22.75x |
P/OCF | 22.39x |
PEG | 2.93x |
EV multiple | 0.17x |
About
Pharming Group N. V. is a biopharmaceutical company dedicated to the creation and commercialization of protein replacement therapies and precision medicines. The firm concentrates its efforts on addressing rare diseases and critical unmet medical needs across the United States, Europe, and other international markets.
Similar securities
Based on sector and market capitalization
Report issue